Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
about
Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrierShotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLCerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.Rapid evolution and copy number variation of primate RHOXF2, an X-linked homeobox gene involved in male reproduction and possibly brain functionRole of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid.PLTP is present in the nucleus, and its nuclear export is CRM1-dependentPhospholipid transfer protein reduces phosphorylation of tau in human neuronal cells.Prescription of lipophilic statins to Alzheimer's disease patients: some controversies to consider.Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology?Lipoprotein lipase and phospholipid transfer protein overexpression in human glioma cells and their effect on cell growth, apoptosis, and migration.PLTP regulates STAT3 and NFκB in differentiated THP1 cells and human monocyte-derived macrophages.Phospholipid transfer protein: its impact on lipoprotein homeostasis and atheroslcerosis.A complex chromosomal rearrangement involving chromosomes 2, 5, and X in autism spectrum disorder.Effect of Phospholipid Transfer Protein on Cigarette Smoke Extract-Induced IL-8 Production in Human Pulmonary Epithelial Cells.Deletion of plasma Phospholipid Transfer Protein (PLTP) increases microglial phagocytosis and reduces cerebral amyloid-β deposition in the J20 mouse model of Alzheimer's disease.
P2860
Q24316276-6F187C11-C6BB-43E4-9EF9-028AED57637FQ24669594-40CE590C-D705-4940-A235-471086D8543FQ33771783-5FBA67FF-47DD-4E0C-BFD7-B1ACA514287EQ34046277-5159A2E7-AF84-4F9A-ADE5-6625C51F476BQ35341853-FBD82176-81F0-4F77-85C9-2AC0F91EF562Q37155515-995B58E2-5EEE-4201-8195-6E3B814BB383Q37217609-DA17FDD7-3F6B-4D9F-ACC1-D5D4C0158B9DQ37371327-C997FA4F-76A6-40C0-B5A0-E7185C5C281EQ37801334-87B82EDB-0B78-4360-A764-6D001CF5A684Q38413096-A68A2490-E357-4013-A0AF-4087970906B9Q38730202-45606F2F-FC0C-4369-9A57-1C6F6B25240FQ39502157-CD3A5441-2258-4CA2-9813-B99A17DEB541Q50036926-0D4913F2-9250-4674-BA78-74D9E7473D15Q50307061-20D42F14-BF22-44AE-A461-BCB6086AD0F8Q51460436-FC0285B1-69B3-475B-8FA4-3690019285F2Q55171011-BFE7BBE2-700B-427A-9FD9-9AA9F9422779
P2860
Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Reduced CSF PLTP activity in A ...... ary human astrocytes in vitro.
@en
Reduced CSF PLTP activity in A ...... ary human astrocytes in vitro.
@nl
type
label
Reduced CSF PLTP activity in A ...... ary human astrocytes in vitro.
@en
Reduced CSF PLTP activity in A ...... ary human astrocytes in vitro.
@nl
prefLabel
Reduced CSF PLTP activity in A ...... ary human astrocytes in vitro.
@en
Reduced CSF PLTP activity in A ...... ary human astrocytes in vitro.
@nl
P2093
P2860
P921
P356
P1476
Reduced CSF PLTP activity in A ...... ary human astrocytes in vitro.
@en
P2093
Elaine R Peskind
Hal Kennedy
John J Albers
Lee-Way Jin
Marian C Cheung
Santica M Marcovina
Simona Vuletic
P2860
P304
P356
10.1002/JNR.20458
P577
2005-05-01T00:00:00Z